AMAZON COM INC vs CVS HEALTH Corp, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AMZN and CVS diverge most: on fcf yield, AMZN reads -0.1% and CVS reads 5.4%; on net margin, AMZN reads 8.9% and CVS reads 0.2%. The rest of the comparable metrics sit closer together. What AMZN's price implies is a demanding bet versus history and the cohort (whole-company basis). What CVS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AMZN | CVS |
|---|---|---|
| Price | $232.10 | $107.73 |
| Market cap | $2.52T | $137.8B |
| Sector | Retail | Retail |
| Stage | Mature | Mature |
| P/E | 27.8 | — |
| P/B | 5.71 | 1.77 |
| P/S | 3.40 | 0.34 |
| EV/EBITDA | 16.3 | 17.9 |
| Revenue growth | +14.2% | +7.6% |
| Operating margin | 13.1% | 4.7% |
| Net margin | 8.9% | 0.2% |
| Return on equity | 15.0% | 1.3% |
| Return on assets | 7.2% | 0.4% |
| Return on invested capital | 11.9% | 3.2% |
| FCF yield | -0.1% | 5.4% |
| Dividend yield | — | 2.5% |
| Debt / equity | 0.28 | 0.78 |
| Current ratio | 1.18 | 0.87 |
| Altman Z (solvency) | 7.38 | 2.44 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.